SPC
LKFT

Sigma Planning Corp’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Sigma Planning Corp’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,696
Closed -$259K – 1070
2019
Q3 		$259K Buy
1,696
+49
+3% +$8.03K 0.01% 831
2019
Q2 		$212K Buy
+1,647
New +$195K 0.01% 893

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Sigma Planning Corp's LKFT Position: Q4 2019 in Review

Sigma Planning Corp sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2019, closing a stake of 1,696 shares — an estimated $259K sold.

Sigma Planning Corp first reported a position in LKFT in Q2 2019 and held it in 2 quarters. The position peaked at $259K in Q3 2019. 137 funds tracked by Wall St. Rank hold LKFT as of Q4 2019.

  • Sigma Planning Corp reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2019 after selling out during the quarter.
  • Sigma Planning Corp sold 1,696 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2019, an estimated $259K.
  • Sigma Planning Corp first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2019 and held it in 2 quarters.
  • Sigma Planning Corp's Lakefront Biotherapeutics American Depositary Shares position peaked at $259K in Q3 2019.
  • 137 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2019.

Based on Sigma Planning Corp's 13F filing for Q4 2019, filed 3 Feb 2020.